𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus

✍ Scribed by Stefano Aquaro; Patrizia Bagnarelli; Tania Guenci; Andrea De Luca; Massimo Clementi; Emanuela Balestra; Raffaele Caliò; Carlo-Federico Perno


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
173 KB
Volume
68
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The role of macrophages in the pathogenesis and progression of human immunodeficiency virus (HIV)‐related infection is substantiated by in vitro and in vivo evidence. The unique ability to survive HIV infection and produce viral particles for long periods is postulated. Detailed studies of this phenomenon are lacking. The dynamics of HIV‐1 replication and cumulative virus production was studied in long‐term cultures of macrophages in the presence or in the absence of antiviral drugs. Multiply spliced and unspliced HIV‐RNA production was assessed by quantitative PCR, and the number of infected cells was monitored by FACS analysis. Cumulative HIV‐1 production was determined by a trapezoidal equation, including such parameters as times of collection and experimental values of genomic‐RNA and p24 gag antigen. Unspliced and multiply spliced HIV‐RNA increased linearly after macrophage infection; reached levels of 1.5 × 10^8^ and 2.8 × 10^5^ copies/10^5^ cells, respectively, at day 10; and then remained stable throughout the course of the experiment. Cumulative production of genomic‐RNA and p24 gag antigen was 10^10^ copies/10^6^ cells and 10^7^ pg/10^6^ cells, respectively, with an average of >200 virus particles produced daily by each macrophage. AZT decreased the cumulative production of both genomic‐RNA and p24 gag antigen down to 2.5 × 10^9^ copies and 1.1 × 10^6^ pg/10^6^ cells (73.8% and 88.9% inhibition, respectively) up to day 50 without virus breakthrough. Ritonavir had a limited, but consistent, efficacy on the release of mature virus proteins (about 40% inhibition), but not on HIV‐RNA production. In conclusion, the long‐term dynamics and the high cumulative virus production that characterize HIV‐1 infection of macrophages underscore the peculiar role of these cells as a persistently infected reservoir of HIV. J. Med. Virol. 68:479–488, 2002. © 2002 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Long-term incidence of hepatitis B virus
✍ Yves Benhamou; Marie Bochet; Vincent Thibault; Vincent Di Martino; Eric Caumes; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

Hepatitis B virus (HBV) resistance to lamivudine has not been extensively documented in human immunodeficiency virus (HIV)-infected patients. We studied the long-term incidence of HBV resistance to lamivudine in HIV-positive patients. Sixty-six HIV-HBV-coinfected patients were studied while receivin

Production of human immunodeficiency vir
✍ Claudia Pintér; Antonio G. Siccardi; Alberto Clivio 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 431 KB

## Abstract A human T cell line chronically infected with Human Immunodeficiency Virus (HIV) has been adapted to grow in a chemically defined, protein‐free medium. Virus particles are produced at rates comparable to those of serum‐supplemented cultures; virus preparations free of undesirable protei

Splenic rupture in a human immunodeficie
✍ Richard Fausel; Nora C. J. Sun; Stanley Klein 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB 👁 2 views

Splenic rupture presenting as primary malignant lymphoma of the spleen is a rare event. We report such an occurrence in a young man who had a primary B-cell immunoblastic lymphoma of the spleen and was found to be HIV-positive. We suggest that serologic tests for HIV should be performed in unusual c